Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis

Introduction: The role of serum Monocyte Chemoattractant Protein-1 (MCP-1) as a biomarker of periodontitis is well documented; however, its role in diabetic patients with periodontitis is unknown. Aim : This study was conducted to determine the presence and concentration of serum MCP-1 in diabetic p...

Full description

Bibliographic Details
Main Authors:	Preethi Radhakrishnan, Padma Srikanth, Krishna G Seshadri, Ramya Barani, Maitreya Samanta
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	Glycemic control periodontitis serum Monocyte Chemoattractant Protein-1
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=4;spage=505;epage=510;aulast=Radhakrishnan

Similar Items

Assessment of serum levels of monocyte chemoattractant protein 1 (MCP 1) in patients with periodontitis and atherosclerotic cardiovascular disease
by: Safa A Hamad, et al.
Published: (2022-12-01)

Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment
by: Ching-Wen Chang, et al.
Published: (2018-03-01)

Evaluation of Monocyte Chemoattractant Protein-1 levels as diagnostic biomarker of Diabetic Retinopathy.
by: Shabir Ahmed, et al.
Published: (2022-02-01)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
by: Seong-Kyu Lee
Published: (2017-12-01)

Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease
by: Sujie Jia, et al.
Published: (2019-11-01)

Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis
by: Jiapei Wang, et al.
Published: (2018-06-01)

Role of kidney biomarkers [Kidney injury molecule-1, Calbindin, Interleukin-18 and Monocyte chemoattractant protein-1] in HIV associated pre-eclampsia
by: Soumaya Abdullatif Eltounali, et al.
Published: (2017-10-01)

CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
by: L. V. Matveeva, et al.
Published: (2018-09-01)

The Diagnostic Value of Monocyte Chemoattractant Protein-1, Compared with Procalcitonin, C-reactive Protein, and Lactate in Bacteremia Estimation for Patients with Febrile Neutropenia
by: Ödemiş İlker, et al.
Published: (2020-10-01)

Same Virus, Different Course: The Relationship Between Monocyte Chemoattractant Protein-1 and Surfactant Protein-A Levels And Clinical Course and Prognosis of COVID-19
by: Ferhan KERGET, et al.
Published: (2021-09-01)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
by: Xiangling Wang, et al.
Published: (2020-04-01)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
by: Tannaz Jamialahmadi, et al.
Published: (2022-11-01)

Circulating Monocyte Chemoattractant Protein-1 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Substudy of SHOCK-COOL Trial
by: Wenke Cheng, et al.
Published: (2022-08-01)

Monocyte chemoattractant protein-1 (MCP1) -2581 A/G and interferon gamma (IFNγ) +874 T/A polymorphisms in Iranian population with pulmonary tuberculosis
by: Ailar Jamali, et al.
Published: (2023-10-01)

Estimation of CCL2/MCP-1 levels in serum and gingival crevicular fluid in periodontal health, disease and after treatment – A clinico biochemical study
by: Dandu S M Babu, et al.
Published: (2017-01-01)

Exploring the role of monocyte chemoattractant protein-1 in fibroblast-like synovial cells in rheumatoid arthritis
by: Xiang Tong, et al.
Published: (2021-08-01)

Involvement of chronic inflammation via monocyte chemoattractant protein‐1 in uraemic cardiomyopathy: a human biopsy study
by: Tomoya Nakano, et al.
Published: (2021-08-01)

Serratiopeptidase Attenuates <i>Lipopolysaccharide</i>-Induced Vascular Inflammation by Inhibiting the Expression of Monocyte Chemoattractant Protein-1
by: Vikas Yadav, et al.
Published: (2023-03-01)

A meta-analysis indicates that the regulation of cell motility is a non-intrinsic function of chemoattractant receptors that is governed independently of directional sensing
by: José Luis Rodríguez-Fernández, et al.
Published: (2022-10-01)

Assessing the variability and the role of inflammatory cytokines and monocyte chemoattractant protein-1 (MCP-1) in predicting stroke among hypertensives: A case-control study
by: Samuel Asamoah Sakyi, et al.
Published: (2022-12-01)

Role of cardiovascular disease markers in periodontal infection: Understanding the risk
by: Mili Gupta, et al.
Published: (2015-01-01)

The Effects of High Fat Diet on the Incidence of Obesity and Monocyte Chemoattractant Protein-1 Levels on Histological Changes in Prostate Wistar Rats
by: Syarif, et al.
Published: (2024-03-01)

Ascorbic Acid vs Calcitriol in Influencing Monocyte Chemoattractant Protein-1, Nitric Oxide, Superoxide Dismutase, as Markers of Endothelial Dysfunction: In Vivo Study in Atherosclerosis Rat Model
by: Heriansyah T, et al.
Published: (2023-03-01)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
by: Juan Antonio Franco-Peláez, et al.
Published: (2020-09-01)

Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells
by: Hung-Hsing Chao, et al.
Published: (2017-11-01)

Significant Therapeutic Effects of Adult Human Neural Stem Cells for Spinal Cord Injury Are Mediated by Monocyte Chemoattractant Protein-1 (MCP-1)
by: Chung Kwon Kim, et al.
Published: (2022-04-01)

Impaired neutrophil and monocyte chemotaxis in chronic and aggressive periodontitis and effects of periodontal therapy
by: R Santhosh Kumar, et al.
Published: (2012-01-01)

Effect of Flavonoids on MCP-1 Expression in Human Coronary Artery Endothelial Cells and Impact on MCP-1-Dependent Migration of Human Monocytes
by: Lea Brüser, et al.
Published: (2023-11-01)

Green Tea Polyphenol Epigallocatechin-3-Gallate Inhibits TNF-a-Induced Production of Monocyte Chemoattractant Protein-1 in Human Umbilical Vein Endothelial Cells
by: Ze-Mu Wang, et al.
Published: (2014-05-01)

Elevated Monocyte Chemoattractant Protein-1 as the Independent Risk Factor of Delirium after Cardiac Surgery. A Prospective Cohort Study
by: Jakub Kaźmierski, et al.
Published: (2021-04-01)

Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus
by: Eirini Kostopoulou, et al.
Published: (2024-02-01)

Disruption of Monocyte and Macrophage Homeostasis in Periodontitis
by: Abdulrahman Almubarak, et al.
Published: (2020-02-01)

Decreased phagocytic function in neutrophils and monocytes from peripheral blood in periodontal disease
by: Valéria Martins Araújo Carneiro, et al.
Published: (2012-10-01)

Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
by: Bancha Satirapoj, et al.
Published: (2018-09-01)

Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis
by: Supanat Worawichawong, et al.
Published: (2016-12-01)

Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder
by: Fang Cao, et al.
Published: (2023-05-01)

Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke
by: Alice Y.W. Chang, et al.
Published: (2014-11-01)

Allosteric modulation of chemoattractant receptors
by: Maria Candida Cesta, et al.
Published: (2016-05-01)

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
by: Robert H. Vonderheide, et al.
Published: (2020-11-01)

Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c
by: Ming-Yu Lien, et al.
Published: (2020-11-01)